BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sise ME, McQuaid T, Martin P. Sofosbuvir-based hepatitis C therapies in patients with chronic and end-stage kidney disease. Nephrol Dial Transplant 2021:gfab072. [PMID: 33848334 DOI: 10.1093/ndt/gfab072] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Jadoul M, Labriola L, Gordon CE. HCV Can and Should Be Eliminated From Dialysis Units. Am J Kidney Dis 2021;78:487-8. [PMID: 34144101 DOI: 10.1053/j.ajkd.2021.06.001] [Reference Citation Analysis]
2 Cohen-Bucay A, Francis JM, Gordon CE. Progress in hepatitis C virus management in chronic kidney disease. Curr Opin Nephrol Hypertens 2021;30:493-500. [PMID: 34054074 DOI: 10.1097/MNH.0000000000000729] [Reference Citation Analysis]